| Dr Lauri Lee Rogers, PSYD | |
|
9089 Baseline Rd, Suite 200, Rancho Cucamonga, CA 91730-1295 | |
| (909) 980-3567 | |
| (909) 989-3932 |
| Full Name | Dr Lauri Lee Rogers |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 9089 Baseline Rd, Rancho Cucamonga, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013983394 | NPI | - | NPPES |
| 18846 | Other | CA | PROFESSIONAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 18846 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lauri Lee Rogers, PSYD 9089 Baseline Rd, Suite 200, Rancho Cucamonga, CA 91730-1295 Ph: (909) 980-3567 | Dr Lauri Lee Rogers, PSYD 9089 Baseline Rd, Suite 200, Rancho Cucamonga, CA 91730-1295 Ph: (909) 980-3567 |
News Archive
Escalating costs and lengthy clinical trials are major concerns for researchers attempting to boost productivity and efficiency in the field of drug discovery. Biomarkers are emerging as the solution to these problems with their ability to reduce drug development costs and time.
The U.S. Food and Drug Administration today approved Victoza (liraglutide), a once-daily injection to treat type 2 diabetes in some adults.
Proteonomix, Inc., a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, today announced that it has entered into an exclusive worldwide license agreement for a novel source of primary human cells that secrete a factor capable of inhibiting tumor cell growth and causing tumor cell death.
Nationally-acclaimed researcher and award-winning author Dr. Cynthia C. Chernecky warned in a speech at the 11th National Conference on Cancer Nursing Research that silver treated IV connectors could actually cause potentially deadly infections they were supposed to prevent.
Quick-Med Technologies, Inc. announced today that the Food and Drug Administration has issued Guidance to support the classification of the Company's NIMBUS® barrier gauze wound dressings as Class II medical devices.
› Verified 7 days ago
Victor Cordova, PSY.D Psychologist Medicare: Medicare Enrolled Practice Location: 9033 Base Line Rd Ste A, Rancho Cucamonga, CA 91730 Phone: 909-922-2442 Fax: 909-999-2377 | |
Dr. Scott Su, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 8300 Utica Ave Ste 245, Rancho Cucamonga, CA 91730 Phone: 909-247-5992 | |
Dr. Krystle Rose Frazier-philo, ED.D. Psychologist Medicare: Medicare Enrolled Practice Location: 9600 Center Ave Ste 160, Rancho Cucamonga, CA 91730 Phone: 800-434-8923 | |
Veronica Nakla, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9377 Haven Ave Ste 100, Rancho Cucamonga, CA 91730 Phone: 909-906-1505 | |
Dr. Stacey Waring, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 9500 Etiwanda Ave, Rancho Cucamonga, CA 91739 Phone: 909-463-5179 | |
Dr. Jerry M Goffman, PHD. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8253 White Oak Ave, Rancho Cucamonga, CA 91730 Phone: 951-312-1041 |